Weight loss drugs can halve heart patients’ risk of early death, study finds
Weight loss drugs can halve heart patients’ risk of early death, study finds
Weight loss drugs can halve heart patients’ risk of early death, study finds
GLP-1 agonists could be given to millions with heart conditions to help them stay out of hospital and live longer
Weight loss drugs can reduce by half the risk of heart patients being hospitalised or dying early, according to the largest study of its kind.
The class of drugs, known as GLP-1 agonists, have been found to offer “dramatic benefits” to heart patients, significantly cutting their risk of falling seriously ill or dying prematurely from any cause.
The discovery, revealed at the world’s largest heart conference in Madrid, mean they could be given to millions of heart patients to help them stay out of hospital and live longer.
How wonderful, right just when Eli Lilly halted shipments to the UK.
As a sufferer of heart failure since the age of 16, my rage at those greedy knobheads is incandescent. I'm not raging at people who buy GLP-1 pens to lose a bit of fat when they don't need it, those drugs are truly revolutionary in their benefits. Sadly producers know it and will charge eye-wateringly high prices for the product. They are the ones to blame, not Brenda down the road who's on the Ozempic for £200 a pop because she wants to be a size 6 instead of a size 8.
I saw a comment by another Lemming on another post suggesting that generics might happen soon as semaglutide patent was not renewed. I can only hope this is true.
Earliest some countries (china, india, brazil and a couple more) will see generics is 2026, US is probably closer to 2030.